Syndetics omslagsbild
Bild från Syndetics

Psychopharmacology of the Developmental Disabilities [electronic resource] / edited by Michael G. Aman, Nirbhay N. Singh.

Medverkande: Materialtyp: TextSerie: Disorders of Human Learning, Behavior, and CommunicationUtgivningsuppgift: New York, NY : Springer New York : Imprint: Springer, 1988Utgåva: 1st ed. 1988Beskrivning: XVI, 277 p. online resourceInnehållstyp:
  • text
Medietyp:
  • computer
Bärartyp:
  • online resource
ISBN:
  • 9781461387749
Ämnen: Fler format: Printed edition:: Ingen titel; Printed edition:: Ingen titel; Printed edition:: Ingen titelDDK-klassifikation:
  • 616.89 23
Library of Congress (LC) klassifikationskod:
  • RC434.2-574
Onlineresurser:
Innehåll:
1 Patterns of Drug Use: Methodological Considerations, Measurement Techniques, and Future Trends -- 2 Litigation and the Use of Psychoactive Drugs in Developmental Disabilities -- 3 Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons -- 4 Neuroleptic Medications for Persons with Developmental Disabilities -- 5 Antiepileptic Drugs -- 6 Other Psychotropic Drugs -- 7 Novel Psychoactive Agents in the Treatment of Developmental Disorders -- 8 Vitamin, Mineral, and Dietary Treatments -- 9 Tardive Dyskinesia and Developmental Disabilities -- 10 Issues in Behavioral Pharmacology: Implications for Developmental Disorders -- 11 Conclusions -- Glossary of Psychotropic Drug Classes, Generic Names, and Trade Names -- Author Index.
I: Springer Nature eBookSammanfattning: Psychopharmacology of the Developmental Disabilities explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. Psychopharmacology of the Developmental Disabilities provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents.
Inga fysiska exemplar för denna post

1 Patterns of Drug Use: Methodological Considerations, Measurement Techniques, and Future Trends -- 2 Litigation and the Use of Psychoactive Drugs in Developmental Disabilities -- 3 Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons -- 4 Neuroleptic Medications for Persons with Developmental Disabilities -- 5 Antiepileptic Drugs -- 6 Other Psychotropic Drugs -- 7 Novel Psychoactive Agents in the Treatment of Developmental Disorders -- 8 Vitamin, Mineral, and Dietary Treatments -- 9 Tardive Dyskinesia and Developmental Disabilities -- 10 Issues in Behavioral Pharmacology: Implications for Developmental Disorders -- 11 Conclusions -- Glossary of Psychotropic Drug Classes, Generic Names, and Trade Names -- Author Index.

Psychopharmacology of the Developmental Disabilities explores the use of psychotropic and antiepileptic medications in developmentally disabled patients. A distinguished group of international experts offers comprehensive coverage of traditional psychotropic as well as novel pharmacological agents, antiepileptic drugs, and diet and vitamin treatments. Issues related to litigation, measurement of blood levels, tardive dyskinesia, and behavioral pharmacology are discussed in detail. Psychopharmacology of the Developmental Disabilities provides an excellent overview of what is known about psychoactive drugs and an awareness of the principal social and medical issues posed by these agents.

Accessibility summary: This PDF is not accessible. It is based on scanned pages and does not support features such as screen reader compatibility or described non-text content (images, graphs etc). However, it likely supports searchable and selectable text based on OCR (Optical Character Recognition). Users with accessibility needs may not be able to use this content effectively. Please contact us at accessibilitysupport@springernature.com if you require assistance or an alternative format.

Inaccessible, or known limited accessibility

No reading system accessibility options actively disabled

Publisher contact for further accessibility information: accessibilitysupport@springernature.com

Licensed e-book